Eurostars

Programme of the Eureka network that funds collaborative R&D projects led by SMEs.

Profile being verified

Stage
Non-dilutive R&D grants to consortia across recorded rounds
Ticket
Eurostars funding of EUR 1 to 1.3 M per consortium (including EUR 772 000 for Terapet)
Location
Not specified
Tracked rounds
4

What they look for

According to the article, the programme is co-funded by the European Union and supported in particular by Innosuisse; Eureka is an intergovernmental network of 47 countries. The recorded rounds are consortium funding (MastCURe for Allegria, ASCEND for Mabylon, TheraVivo for Terapet, Nexopore for AlveoliX).

Recent investments

Recorded Swiss rounds: Terapet (grant, EUR 772 000, April 2026, lead), Allegria Therapeutics (grant, amount not disclosed, April 2026, lead), Mabylon (grant, amount not disclosed, April 2026, lead), AlveoliX (grant, amount not disclosed, June 2026, lead).

Rounds tracked by FundSwiss